EUPRAXIA PHARMACEUTICALS INC.
Profile
Company Names
EUPRAXIA PHARMACEUTICALS INC.
Addresses
201-2067 CADBORO BAY RD., VICTORIA, A1 V8R 5G4
2590 CADBORO BAY ROAD, UNIT 204, VICTORIA, A1 V8R 5J2
1240-666 BURRARD STREET, VANCOUVER, A1 V6C 2X8
Phone Numbers
250-590-3968
(250) 590-3968
604-685-0088
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2012
State Incorporated:
BRITISH COLUMBIA, CANADA
Total Amount Raised:
$2,500,870.00
Number of Funding Rounds:
8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-10-31
$1,894,413.00
$1,894,413.00
$0.00
Equity
7
2023-08-18
$128,394.00
$128,394.00
$0.00
Equity
6
2016-04-05
$37,951.00
$37,951.00
$0.00
Equity
5
2013-07-24
$24,277.00
$24,277.00
$0.00
Equity
4
2013-06-30
$23,782.00
$23,782.00
$0.00
Equity
3
2012-12-21
$376,848.00
$645,089.00
$268,241.00
Equity
2
2012-10-03
$5,066.00
$12,665.00
$7,599.00
Equity
1
2012-08-31
$10,139.00
$10,139.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL
BRENNAN
EXECUTIVE OFFICER
JOSEPH
FREEDMAN
DIRECTOR
BROOKFIELD SPECIAL SITUATIONS FUND III L.P.
| BROOKFIELD SPECIAL SITUATIONS FUND III (NR B) L.P.
| BROOKFIELD ASSET MANAGEMENT INC.
| BROOKFIELD SPECIAL SITUATIONS FUND III (NR A) L.P.
| ISLAND TIMBERLANDS FINANCE CORP
| BROOKFIELD CAPITAL PARTNERS IV L.P.
| BROOKFIELD CAPITAL PARTNERS IV (CR) L.P.
| BROOKFIELD CAPITAL PARTNERS IV (ER) L.P.
| ATOMIC REACH INC.
| BEELINE FINANCIAL HOLDINGS INC.
| EASTSIDE DISTILLING, INC.
| EUPRAXIA PHARMACEUTICALS INC.
| RAD TECHNOLOGIES INC.
PAUL
GEYER
DIRECTOR
DAVID
STADNYK
DIRECTOR
GEORGE
TSAFALAS
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-10-31
